• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    423.79 Up 12.80(3.11%) Dec 18, 4:00PM EST
    |After Hours : 423.00 Down 0.79 (0.19%) Dec 18, 7:41PM EST
    Add to Portfolio
    Prev Close:410.99
    Open:415.71
    Bid:417.01 x 100
    Ask:N/A
    1y Target Est:404.30
    Beta:1.62
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:412.40 - 424.44
    52wk Range:262.97 - 437.64
    Volume:733,769
    Avg Vol (3m):827,605
    Market Cap:42.72B
    P/E (ttm):144.89
    EPS (ttm):2.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 3.11%42.72B
    AMGNUp 3.06%128.16B
    NVSUp 2.47%228.74B
    RHHBYUp 2.39%250.73B

    Key Statistics

    Forward P/E (1 yr):35.98
    P/S (ttm):15.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :9.95
    Quarterly EPS Est (Dec-14) :2.75
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback